Targeted therapies for bone sarcomas

af Heymann, Dominique, Rédini, Françoise
Udgivet 2013

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

af Redini, Françoise, Heymann, Dominique
Udgivet i Front Oncol (2015)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

af Verrecchia, Franck, Rédini, Françoise
Udgivet i Front Oncol (2018)

RANKL/RANK/OPG: key therapeutic target in bone oncology

af Ando, Kosei, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Udgivet 2008

TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment

af Picarda, Gaëlle, Trichet, Valérie, Téletchéa, Stéphane, Heymann, Dominique, Rédini, Françoise
Udgivet 2011

Mifamurtide for the treatment of nonmetastatic osteosarcoma

af Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique
Udgivet 2011

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression

af Lézot, Frédéric, Corre, Isabelle, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Udgivet i Cells (2020)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

af Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Udgivet i Cells (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors

af Talbot, Julie, Dupuy, Maryne, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Udgivet i Biomolecules (2020)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

af Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Udgivet i Int J Mol Sci (2019)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

af Morice, Sarah, Danieau, Geoffroy, Rédini, Françoise, Brounais-Le-Royer, Bénédicte, Verrecchia, Franck
Udgivet i Cancers (Basel) (2020)

Molecular Alterations Associated with Osteosarcoma Development

af Ando, Kosei, Mori, Kanji, Verrecchia, Franck, Marc, Baud'huin, Rédini, Françoise, Heymann, Dominique
Udgivet 2012

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

af Ando, Kosei, Heymann, Marie-Françoise, Stresing, Verena, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Udgivet 2013

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

af Lamora, Audrey, Mullard, Mathilde, Amiaud, Jérôme, Brion, Régis, Heymann, Dominique, Redini, Françoise, Verrecchia, Franck
Udgivet i Oncotarget (2015)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression

af Lamora, Audrey, Talbot, Julie, Mullard, Mathilde, Brounais-Le Royer, Benedicte, Redini, Françoise, Verrecchia, Franck
Udgivet i J Clin Med (2016)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

af Le Goff, Benoit, Soltner, Elise, Charrier, Céline, Maugars, Yves, Rédini, Françoise, Heymann, Dominique, Berthelot, Jean-Marie
Udgivet 2009

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

af Gobin, Bérengère, Moriceau, Gatien, Ory, Benjamin, Charrier, Céline, Brion, Régis, Blanchard, Frederic, Redini, Françoise, Heymann, Dominique
Udgivet 2014

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer

af Biteau, Kevin, Guiho, Romain, Chatelais, Mathias, Taurelle, Julien, Chesneau, Julie, Corradini, Nadège, Heymann, Dominique, Redini, Françoise
Udgivet i Am J Cancer Res (2016)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

af Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Udgivet 2014

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

af Grimaud, Eva, Soubigou, Luc, Couillaud, Séverine, Coipeau, Patrick, Moreau, Anne, Passuti, Norbert, Gouin, François, Redini, Françoise, Heymann, Dominique
Udgivet 2003